MSA
ELV icon

Marino Stram & Associates’s Elevance Health ELV Stock Holding History

Marino Stram & Associates’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-6
Closed -$2K – 223
2019
Q1 		$2K Sell
6
-4
-40% -$1.16K ﹤0.01% 523
2018
Q4 		$3K Buy
10
+2
+25% +$550 ﹤0.01% 401
2018
Q3 		$2K Hold
8
– – ﹤0.01% 400
2018
Q2 		$2K Buy
+8
New +$1.85K ﹤0.01% 401

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Marino Stram & Associates's ELV Position: Q2 2019 in Review

Marino Stram & Associates sold out of Elevance Health (ELV) in Q2 2019, closing a stake of 6 shares — an estimated $2K sold.

Marino Stram & Associates first reported a position in ELV in Q2 2018 and held it in 4 quarters. The position peaked at $3K in Q4 2018. 1,030 funds tracked by Wall St. Rank hold ELV as of Q2 2019.

  • Marino Stram & Associates reported no remaining Elevance Health position as of Q2 2019 after selling out during the quarter.
  • Marino Stram & Associates sold 6 Elevance Health shares in Q2 2019, an estimated $2K.
  • Marino Stram & Associates first reported a position in Elevance Health in Q2 2018 and held it in 4 quarters.
  • Marino Stram & Associates's Elevance Health position peaked at $3K in Q4 2018.
  • 1,030 funds tracked by Wall St. Rank held Elevance Health as of Q2 2019.

Based on Marino Stram & Associates's 13F filing for Q2 2019, filed 19 Jul 2019.